关于我们
Diasome Pharmaceuticals is a clinical-stage biopharmaceutical company pioneering hepatocyte cell drug targeting to restore hepatocyte metabolism and treat metabolic diseases. Diasome's Hepatocyte Targeting Platform reestablishes hepatocyte function, addressing the root cause of dysregulations central to major metabolic diseases such as diabetes, obesity, and dyslipidemia. Diasome aims to deliver superior patient outcomes and enhanced disease management by leveraging the hepatocyte's natural regulatory functions.
- 网站
-
https://www.diasome.com
Diasome Pharmaceuticals, Inc.的外部链接
- 所属行业
- 生物技术
- 规模
- 2-10 人
- 类型
- 私人持股
- 领域
- Type 1 and Type 2 Diabetes、Obesity、Nanotechnology、Oral Protein Delivery和Hepatic Targeted Insulin Therapies